XPH News and Press, SPDR S&P Pharmaceuticals From 04/24/24

First Quarter 2024 Highlights: Sales of $3.26 billion, up 9% in U.S. dollars and 6% organically compared to the first quarter of 2023 GAAP Diluted EPS of $0.87, up 23% compared to prior year Adjusted Diluted EPS of $0.80, up 16% compared to prior year GAAP and Adjusted...

Amphenol Corporation (NYSE: APH) today released its 2023 Sustainability Report. “Amphenol continues to make a positive impact on the environment, the communities in which we operate and our global team members, all while delivering exceptional performance for our shareholders,” ...

2024-04-16 10:30:00 ET Summary The rise in rates last week pushed the 10-year to its highest level since the peak at 5% in October of last year. Gold has been setting new highs, trading above $2400 at one point on Friday before succumbing to some profit taking. Year-to-date, t...

2024-04-15 09:50:00 ET Summary Powerful investment themes, such as AI, can capture the market’s collective imagination. Taken to an extreme, however, they can also trigger distortions across and within the markets. In our 2Q 2024 Equity Outlook, we examine key historic dist...

2024-04-09 09:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Amphenol Corporation (NYSE: APH) announced today the pricing of its offering of $450 million aggregate principal amount of senior notes due 2027 (the “2027 Notes”), $450 million aggregate principal amount of senior notes due 2029 (the “2029 Notes”) and $600 million agg...

2024-03-28 10:38:32 ET Summary The SPDR S&P Pharmaceuticals ETF offers broad-based exposure to the U.S. pharmaceuticals sector, making it a good option for investing in the industry. XPH tracks the performance of the S&P Pharmaceuticals Select Industry Index and provides a...

2024-03-22 11:15:00 ET Summary A positive January for U.S. stocks is typically a prelude to a positive year, with our analysis finding the correlation to hold 80% of the time since 1928. Stocks look well-positioned to outperform bonds and cash again this year, but high valuations ...

2024-03-20 09:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-03-18 12:23:05 ET More on SPDR S&P Pharmaceuticals ETF Seeking Alpha’s Quant Rating on SPDR S&P Pharmaceuticals ETF Dividend scorecard for SPDR S&P Pharmaceuticals ETF Read the full article on Seeking Alpha For further details see: ...